• Follow Us On : 

Jacobson Pharmas Proposed Spin-off and Separate Listing of JBM Limited on The Main Board of The Stock Exchange of Hong Kong Limited


Redaksi | Jumat,15 Januari 2021 - 21:19:59 WIB
Dibaca: 660 kali 
Jacobson Pharmas Proposed Spin-off and Separate Listing of JBM Limited on The Main Board of The Stock Exchange of Hong Kong Limited

Declaration of Conditional Special Interim Dividend

HONG KONG SAR - 15 January 2021 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced the declaration of a conditional special interim dividend by way of a distribution in specie of an aggregate of 241,777,625 JBM Shares, representing approximately 27.1% of the total number of JBM Shares in issue immediately upon completion of the proposed spin-off, to the qualifying shareholders.

As of today, the total number of issued shares of the Company ("Shares") is 1,934,221,000. Assuming there is no change in the total number of shares from today up to 29 January 2021 (the "Record Date"), the qualifying shareholders will receive one JBM Share for every eight Shares held on the Record Date.

The distribution is conditional on the public offer becoming unconditional in all respects. If such condition is not satisfied, the proposed spin-off will not take place and the distribution will not be made.


Akses Wahanariau.com Via Mobile m.Wahanariau.com
Untuk Berbagi Berita / Informasi / Peristiwa
Silahkan SMS ke nomor HP : 085271472010
atau email ke alamat : [email protected]
Harap camtumkan detail data diri Anda
Pengutipan Berita dan Foto, Cantumkan Wahanariau.com Sebagai Sumber Tanpa Penyingkatan
TULIS KOMENTAR
BERITA TERKAIT
Rabu,23 September 2020

Jacobson Pharma Submits Form A1 to Spin-off Its Branded Healthcare Business

CHINA - Media OutReach - 23 September 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pha

Jumat,26 November 2021

Jacobson Pharma Announces FY2022 Interim Results

Robust Growth of 11.6% in Generics Business Amidst the Pandemic; Confident about Sustaining Str

Kamis,31 Oktober 2019

Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U

Expands Branded Product Portfolio and Develops New Markets for Gastrointestinal and Respiratory Prod

Kamis,22 November 2018

Jacobson Pharma Announces FY2019 Interim Results

Profit from Operations Leapt by 40.7% to HK$158.6 Million Declares Interim Dividend of HK1

Selasa,26 November 2019

Jacobson Pharma Announces FY2020 Interim Results

Profit Attributable to Shareholders Lifted by 30.5% Portfolio and Market Expansion to Harness Gro

Kamis,27 Agustus 2020

Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SEs COVID-19 Vaccine Candidate in Hong Kong and Macau

CHINA - Media OutReach - 27 August 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pharma

BERITA LAINNYA
Kamis,24 November 2022

Kalahkan Bali 11-1, Tim Futsal PWI Riau Lolos Semi Final Porwanas XIII 2022

MALANG - Tim futsal PWI Riau U-40 cukur Bali 11-1 pada babak perempat final Pekan Olahraga Wartawan

Kamis,24 November 2022

Bulu Tangkis Riau Raih Medali Perunggu di Porwanas XIII

MALANG - Tim bulu tangkis beregu Riau berhasil menyabet medali perunggu pada Pekan Olahraga Wartawan

Kamis,24 November 2022

Porwanas XIII di Malang, Cabor Bridge Sumbang Medali Perunggu untuk PWI Riau

MALANG - Tim bridge beregu sumbang medali perunggu untuk Kontingen PWI Riau pada Pekan Olahraga Wart

BERGABUNG DI SINI
KABAR POPULER
IKUTI BERITA KAMI